Degenerative diseases are progressive conditions that cause chronic pain, and they sometimes resist conventional treatment methods. Ketamine is a valuable option for those who have not responded to traditional pain management. When ketamine is administered intravenously at sub-anesthetic doses, it targets specific pain pathways in the central nervous system. Here is more information on degenerative diseases, how ketamine infusions work, and how they benefit patients experiencing persistent pain:
What Are Degenerative Diseases?
Degenerative diseases are conditions in which the body’s tissues or organs progressively deteriorate over time. Common examples include osteoarthritis, Parkinson’s disease, multiple sclerosis, and degenerative disc disease; these conditions often produce persistent pain. While NSAIDs and physical therapy are commonly used to manage pain, each approach has limitations that affect its effectiveness. Ketamine infusions are an alternative treatment option available in pain management settings.
What Are Ketamine Infusions?
Ketamine is an anesthetic agent with analgesic properties, and it was first approved by the FDA in 1970. When administered as an infusion in a controlled clinical setting, ketamine is delivered intravenously under medical supervision. Dosing is carefully calibrated to target pain pathways rather than induce anesthesia.
The infusion process may involve a series of sessions scheduled over days or weeks. Patients remain conscious throughout the procedure, and medical staff continuously monitor vital signs, including heart rate, blood pressure, and oxygen levels. Some patients may experience mild dissociative effects during the infusion, such as altered perception or a sense of detachment, which subside once the session concludes.
How Can They Relieve Pain?
Ketamine works primarily by blocking N-methyl-D-aspartate (NMDA) receptors in the brain and spinal cord. When the nervous system becomes sensitized over time, these receptors can contribute to the transmission and amplification of pain signals associated with chronic pain. By interrupting this transmission process, ketamine reduces the intensity and frequency of pain signals, and patients may experience relief.
Degenerative diseases may cause central sensitization; this phenomenon makes the nervous system hyperresponsive to pain. Standard analgesics rarely address this underlying mechanism. Because ketamine’s NMDA-blocking action targets sensitization directly, it can offer relief where other treatments fail, making it a valuable option for patients with complex, treatment-resistant pain conditions.
What Are the Benefits?
Ketamine infusions for chronic pain conditions have several potential benefits:
- Rapid onset of relief: Patients may report noticeable pain reduction within hours to days of their first infusion.
- Prolonged relief: Some patients may experience pain relief that extends beyond the infusion period, though individual outcomes vary.
- Effectiveness in treatment-resistant cases: Ketamine benefits patients who have not responded adequately to conventional pain therapies.
A thorough medical evaluation before treatment helps identify suitable candidates.
Consult a Pain Management Specialist
Ketamine infusions represent a clinically supported option for patients living with chronic pain from degenerative diseases. By targeting the nervous system’s pain pathways, they offer a different mechanism than conventional treatments, and a pain management specialist can review your medical history, current treatments, and specific condition to determine whether this approach fits your situation. If you experience chronic pain, schedule a consultation today.
